Results 1 to 10 of about 905 (175)

Mortalidad evitable por enfermedades vasculares periféricas

open access: yesRevista Cubana de Higiene y Epidemiología
OBJETIVO: describir la mortalidad evitable por enfermedades vasculares periféricas en Cuba, año 2005. MÉTODOS: se realizó un estudio descriptivo, retrospectivo sobre la mortalidad evitable por enfermedades vasculares periféricas en Cuba año 2005, para lo
Ulises de Jesús Gallardo Pérez   +3 more
doaj   +1 more source

Enfermedad de Fabry y Enfermedad Vascular Cerebral

open access: yesArchivos de Neurociencias, 2022
La enfermedad de Fabry (EF) es una patología genética ligada al cromosoma X (manifestada predominantemente en hombres y mujeres portadoras), causada por el déficit de la enzima alfa α-galactosidasa A (también llamada ceramida trihexosidasa) que cataliza la escisión hidrolítica de la molécula terminal de galactosa de Gb3 (globotriaosilceramida).
Enrique Alexander Pérez Jovel   +6 more
openaire   +1 more source

Fiabilidad del coagulómetro portátil en pacientes con ictus isquémico agudo tratados con fibrinólisis intravenosa

open access: yesNeurología, 2020
Resumen: Introducción: La eficacia de la fibrinólisis intravenosa como tratamiento en el ictus isquémico agudo depende de la rapidez en su administración. Para reducir el riesgo de complicaciones hemorrágicas existen contraindicaciones, como una INR ≥ 1,
D. Guisado-Alonso   +7 more
doaj   +1 more source

Relación entre enfermedades y rendimiento de granos de soja

open access: yesAgronomía Mesoamericana, 2021
Introducción. Las enfermedades vasculares y del follaje se encuentran entre los factores más relevantes que afectan la producción de soja (Glycine max). Objetivo.
M. Lavilla, A. Ivancovich
doaj   +1 more source

Essential lipid autacoids rewire mitochondrial energy efficiency in metabolic dysfunction‐associated fatty liver disease

open access: yesHepatology, EarlyView., 2022
Increased liver content of DHA‐derived small lipid autacoids (i.e resolvin D1 and maresin 1) associates with enhanced mitochondrial oxidative phosphorylation, fatty acid β‐oxidation and bioenergetic metabolic flux. These features provide hepatic protection from steatotic, pro‐inflammatory and fibrogenic insults.
Cristina López‐Vicario   +12 more
wiley   +1 more source

Reliability of point-of-care coagulometer measurements in patients with acute ischaemic stroke receiving intravenous fibrinolysis

open access: yesNeurología (English Edition), 2020
Background: Speed of administration conditions the effectiveness of intravenous fibrinolysis in treating acute ischaemic stroke. To reduce the risk of haemorrhagic complications, the intervention is contraindicated in certain cases, such as where the ...
D. Guisado-Alonso   +7 more
doaj   +1 more source

Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study

open access: yesHepatology, EarlyView., 2022
Natural history of liver disease in a large international cohort of children with Alagille syndrome: Results from the GALA study. Abstract Background and Aims Alagille syndrome (ALGS) is a multisystem disorder, characterized by cholestasis. Existing outcome data are largely derived from tertiary centers, and real‐world data are lacking.
Shannon M. Vandriel   +93 more
wiley   +1 more source

Left atrial appendage closure in patients with intracranial haemorrhage and atrial fibrillation

open access: yesNeurología (English Edition), 2020
Introduction: The use of oral anticoagulants in patients with a history of atrial fibrillation (AF) and intracranial haemorrhage (ICH) is controversial on account of the risk of haemorrhagic stroke recurrence. This study presents our experience regarding
F. Fayos-Vidal   +8 more
doaj   +1 more source

Cierre de orejuela en pacientes con hemorragia intracraneal y fibrilación auricular

open access: yesNeurología, 2020
Resumen: Introducción: El uso de anticoagulantes orales es controvertido en pacientes con antecedentes de fibrilación auricular (FA) y hemorragia intracraneal (HIC), por riesgo de recurrencia de ictus hemorrágico.
F. Fayos-Vidal   +8 more
doaj   +1 more source

Long‐term prognosis is associated with residual disease after neoadjuvant systemic therapy but not with initial nodal status

open access: yesBJS (British Journal of Surgery), EarlyView., 2020
This long‐term follow‐up study determined survival rates in a Swedish national cohort of 417 patients with breast cancer who all had neoadjuvant systemic therapy (NAST). Sentinel lymph node biopsy (SLNB) was performed before NAST in clinically node‐negative and after NAST in clinically node‐positive patients.
L. Zetterlund   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy